Sichenzia Ross Ference represented Relmada Therapeutics in the offering. Relmada Therapeutics executed its offering which included the full exercise of the overallotment, consisted of 10,147,059 shares of common...
You must be a Standard 1 Year member to access this content.
Sichenzia Ross Ference represented Inmune Bio in the transaction. Inmune Bio, Inc. executed its registered direct offering of common stock at a purchase price of $22.00 per share...
You must be a Standard 1 Year member to access this content.
Sichenzia Ross Ference LLP represented Alset EHome International Inc. in the transaction. Alset EHome International Inc. (NASDAQ: AEI) executed a public offering, which consisted of 4,700,637 Units (the...
You must be a Standard 1 Year member to access this content.
Sichenzia Ross Ference represented Aegis Capital Corp. in the transaction. MySize, Inc. (NASDAQ: MYSZ) executed the follow-on offering of 2,618,532 shares of its common stock, at a price...
You must be a Standard 1 Year member to access this content.
Sichenzia Ross Ference represented Aegis Capital in the offering. NuZee, Inc. (NASDAQ: NUZE), a leading U.S. single serve pour over coffee co-packer, executed its public offering of...
You must be a Standard 1 Year member to access this content.
Sichenzia Ross Ference LLP represented Aegis Capital Corp. in the transaction. Medigus Ltd. executed its underwritten public offering of 3,258,438 American Depositary Shares (the “ADSs”). The ADSs were...
You must be a Standard 1 Year member to access this content.
